AzTrials
AzTrials

Chronic Low Back Pain (CLBP)FIRM-CLBPNCT07699419

Impairment Based Treatment Versus Modified Functional Restoration Program in Chronic Low Back Pain Patients

A study testing Impairment-based trearment and Modified Functional restoration program in people with Chronic Low Back Pain (CLBP), run by Cairo University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this feasibility study is to evaluate the practicality of conducting a future randomized controlled trial comparing two rehabilitation approaches for older adults with degenerative chronic low back pain: impairment-based treatment (IBT) and a modified short Functional Restoration Program (FRP). Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
Conditions the study is for
Chronic Low Back Pain (CLBP)
What is being tested?
Impairment-based trearment and Modified Functional restoration program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
18 participants
Where
1 siteEgypt
Study dates
1 Jul 2026to 10 Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • ≥ 60 years
  • Chronic Non-Specific Low Back Pain (CNSLBP)
  • Pain duration ≥ 12 weeks
  • No identifiable specific spinal pathology
  • Pain Location
  • Pain localized between the 12th rib and gluteal folds
Show all 27Show fewer
  • With or without non-dermatomal referred pain not extending below the knee
  • Pain Intensity
  • Mean pain intensity ≥ 4/10 on the Numeric Rating Scale (NRS) over the past 7 days
  • Functional Disability
  • Oswestry Disability Index (ODI) ≥ 20% (moderate disability or higher)
  • Mechanical Pain Characteristics
  • Presence of ≥ 2 of the following:
  • Pain aggravated by movement, loading, or prolonged postures
  • Pain relieved by rest or positional change
  • Morning stiffness < 30 minutes
  • Absence of constant, non-mechanical night pain Functional Capacity
  • Able to ambulate independently (with or without assistive device)
  • Able to actively participate in an exercise-based rehabilitation program
  • Clinical Stability
  • Stable medication regimen (analgesics, anti-inflammatories, or related drugs) for ≥ 4 weeks
  • No planned changes in pharmacological treatment during the study period
  • Cognitive \& Communication Ability
  • Able to understand study procedures and follow instructions
  • MMSE ≥ 24 (or equivalent cognitive screening)
  • Consent
  • Provides written informed consent

Who cannot join

  • 1. Specific Spinal Pathology ("Red Flags")
  • Suspected or confirmed:
  • Spinal fracture
  • Malignancy
  • Spinal infection
  • Inflammatory spondyloarthropathy
Show all 28Show fewer
  • Clinical indicators:
  • Unexplained weight loss Fever or systemic illness History of significant trauma
  • 2. Radicular or Neurological Involvement
  • Radiculopathy defined by ANY of:
  • Dermatomal pain radiating below the knee
  • Progressive motor weakness
  • Objective neurological deficit (sensory, reflex, or motor)
  • 3. Lumbar Spinal Stenosis (Severe)
  • Neurogenic claudication limiting walking to < 100 meters, OR
  • Symptoms not relieved by rest or flexion
  • 4. Prior Surgical or Structural Conditions Lumbar spine surgery within the past 12 months
  • 5. Medical Contraindications to Exercise
  • Severe osteoporosis with high fracture risk
  • Uncontrolled cardiovascular, respiratory, or metabolic disease
  • Any condition precluding safe participation in rehabilitation
  • 6. Cognitive or Behavioral Barriers
  • Severe cognitive impairment (MMSE < 24)
  • Inability to comply with study procedures
  • 7. Confounding Treatment Factors
  • Participation in structured physiotherapy or rehabilitation within the past 3 months
  • Planned concurrent rehabilitation during the study
  • 8. Psychosocial Confounders Ongoing litigation or compensation claims related to low back pain

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Mariam Wael, Bachelor of physiotherapy contact

201117614968

merowael14@gmail.com

Egypt1 site
  • Recovery City Clinic

    Cairo, Cairo Governorate

Other trials in Egypt

About this study

Official title: FIRM-CLBP: a Randomized Controlled Feasibility Trial Comparing Impairment-based Treatment With a Modified Functional Restoration Program in Older Adults With Chronic Low Back Pain

The aim of this feasibility study is to evaluate the practicality of conducting a future randomized controlled trial comparing two rehabilitation approaches for older adults with degenerative chronic low back pain: impairment-based treatment (IBT) and a modified short Functional Restoration Program (FRP).

Impairment-based treatment is an individualized approach in which interventions are tailored to the patient's specific physical deficits, such as limitations in mobility, strength, and motor control. In contrast, the Functional Restoration Program is a structured, standardized approach focusing on improving overall functional capacity through progressive exercise, movement retraining, and activity-based rehabilitation.

Participants will be randomly allocated to one of the two groups. Both interventions will be delivered by trained physiotherapists following standardized protocols over a 6-week period, with supervised sessions conducted according to a predefined rehabilitation schedule.

Being tested
Impairment-based trearment, Modified Functional restoration program
Keywords
LBP, Old age, Impairment, Functional

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Impairment-based trearmentOther

    Subgroup 1 - Lumbar Mobility Deficits Clinical characteristics Localized low back pain Restricted lumbar range of motion Segmental hypomobility Pain at end-range movement Stiffness with prolonged posture Subgroup 2 - Movement Coordination Impairment Clinical characteristics Recurrent low back pain Pain aggravated by movement Poor trunk control Difficulty maintaining neutral spine Aberrant movement patterns during functional tasks Subgroup 3 - Low Back Pain with Referred Lower Extremity Pain (Non-Radicular) Clinical characteristics Low back pain associated with referred pain to the buttock or thigh (above the knee) No neurological deficit on examination Symptoms influenced by movement or loading Mechanical pain behavior

  • Modified Functional restoration programOther

    The modified short Functional Restoration Program (FRP) is a structured, time-efficient rehabilitation approach designed to improve functional capacity in patients with chronic low back pain. It is based on a biopsychosocial model and combines progressive physical reconditioning with functional task training and patient education. The program includes aerobic conditioning, strengthening exercises, movement retraining, and graded activity exposure, with emphasis on restoring tolerance to daily activities rather than focusing solely on pain reduction.

    In this modified short version, the program is adapted for older adults and delivered over a limited timeframe, with standardized session content and progression criteria to ensure consistency, safety, and feasibility within a clinical outpatient setting.

Study groups in NCT07699419
Study groupRoleWhat they receive
Impairment-based treatment groupActive comparatorNot described
Receives: Other: Impairment-based trearment
Modified short functional restoration programActive comparatorNot described
Receives: Other: Modified Functional restoration program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity

    -Numerical pain rating scale (NPRS) from 1 to 10 , minimum 1 and maximum 10 . The bigger the numbers means the worse .

    Measured: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow up (1 month post intervention)

  2. Function

    Modified Oswestry disability Index

    the MOLBPDQ consists of 10 patient-completed questions in which the response options are presented as 6-point Likert scales. Scores range from 0% (no disability) to 100% (most severe disability).

    Measured: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)

  3. Strength

    Hand held dynamometer (activ force 2)

    Measured: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow up (1 month post intervention)

  4. Eligibility rate

    Eligibility rate will be calculated as the proportion of screened participants who meet the study eligibility criteria. All individuals assessed for participation will be recorded, including those who are eligible and those who are excluded with reasons for exclusion.

    Eligibility Rate (%) = Number of Eligible Participants ÷ Number of Screened Participants × 100

    Measured: Post intervention (week 6)

  5. Retention

    Participant Retention Rate

    Description:

    Percentage of enrolled participants who complete the study through the final follow-up assessment, as determined from study participation and completion records.

    Unit of Measure:

    Percentage (%)

    Measurement Tool:

    Study participation and completion records

    Measured: Post intervention (week 6) Follow up (1 month post intervention)

  6. Intervention fidelity

    Percentage of predefined treatment components delivered according to the study protocol, as assessed using a standardized intervention fidelity checklist completed by an independent assessor during treatment sessions. Fidelity scores will be calculated as the proportion of protocol-required components successfully delivered.

    Unit of Measure:

    Percentage (%)

    Measurement Tool:

    Standardized Intervention Fidelity Checklist

    Measured: Post intervention (week 6)

  7. Recruitment feasibility

    Determine the recruitment rate (number of eligible and consenting participants per month) among older adults with degenerative chronic low back pain recruited from the clinical setting

    Measured: Post intervention (weak 6)

  8. Safety outcome

    The incidence, type, severity, and relatedness of any adverse events or undesirable effects potentially attributable to the rehabilitation intervention will be monitored and documented throughout the study period. Adverse events may include increased pain, excessive fatigue, symptom aggravation, dizziness, discomfort during or after treatment, or any other unexpected clinical complaint reported by the participant or observed by the therapist.

    Measured: every session

  9. Data completeness

    Data completeness will be assessed by calculating the proportion of completed outcome assessments at each assessment point out of the total expected outcome assessments. Missing or incomplete data will be recorded and reported.

    Measured: Baseline (week zero) post-intervention: Week 6 Follow-up: 1 month post-intervention

Secondary outcomes (5)
  1. Adherence

    Participant adherence will be assessed throughout the intervention period using session attendance records, completion of the prescribed exercise program, and therapist documentation. Attendance adherence will be calculated as the percentage of attended treatment sessions out of the total scheduled sessions. Home exercise adherence will be monitored using a patient exercise diary or checklist, where participants record the frequency of performed exercises. Overall adherence will be considered acceptable when the participant completes at least 80% of the scheduled sessions and prescribed home exercises.

    Adherence rate will be calculated using the following formula:

    Adherence Rate (%) = Number of Completed Sessions or Exercises ÷ Total Prescribed Sessions or Exercises × 100

    Measured: Post intervention (week 6)

  2. Quality of Life outcome

    Short Form 12 Item Health Survey Sf-12 , when the score gets higher it means better outcome.

    Measured: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow-up (1 month post-intervention)

  3. Range of motion

    Goniometer

    Measured: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)

  4. Pressure pain threshold

    Pressure pain threshold will be measured by pressure algometer using Kilogram as a unit of measurement.

    Measured: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)

  5. Acceptability

    Acceptability will be assessed using participant feedback regarding the practicality, ease of use, burden, and overall acceptability of the study procedures and measurement tools. Feedback may be collected using a brief questionnaire, rating scale, or structured interview.

    Measured: Post-intervention: Week 6 Follow-up: 1 month post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jul 2026
  2. Study start1 Jul 2026 (estimated)
  3. Primary completion1 Nov 2026 (estimated)
  4. Study completion10 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
18 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07699419
Sponsor's protocol ID
FIRM-CLBPstudy
Acronym
FIRM-CLBP
Status last verified
Jul 2026
First submitted
28 Apr 2026
Last updated
13 Jul 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Impairment-based trearment and Modified Functional restoration program in people with Chronic Low Back Pain (CLBP), run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 27 inclusion and 28 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 13 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mariam Wael, Bachelor of physiotherapy (201117614968, merowael14@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity (time frame: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow up (1 month post intervention)). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
FIRM-CLBP Clinical Trial NCT07699419 | AzTrials